Retinopatía Diabética en Latinoamérica - Presente y Futuro (Basado en la Guía Práctica Clínica de la Retinopatía Diabética para Latinoamérica)
Samuel Boyd
Citation Information :
Boyd S. Retinopatía Diabética en Latinoamérica - Presente y Futuro (Basado en la Guía Práctica Clínica de la Retinopatía Diabética para Latinoamérica). 2015; 8 (3):12-16.
Prevention of Blindness from Diabetes Mellitus: Report of a WHO consultation in G Engelgau MM et al. The volving diabetes burden in the United States. Annals of Internal Medicine, 2004, 140:945-950.
Tuomilehto J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolenrence. New England Journal of Medicine, 2001, 344:1343-1350.
Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002, 346:393-403.
Resnokoff S et al. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization, 2004, 82:844-851.
Klein R et al. The Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 1984, 102:520-526.
Klein R et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis 30 or more years Archives of Ophthalmolgy, 1984, 102:527-532.
Klein R, Klein BEK, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1991;99:58-62.
Ferris FL. Results of 20 years of research on the treatment of diabetic retinopathy. Preventive Medicine, 1994, 23:740-742.
Encuesta Nacional de Salud 2003 Ministerio de Salud de Chile, http://epi.minsal.cl/epi/html/frames/frame3.htm.
Carrasco E, Perez F, Angel B, Albala C, Santos L, Larenas G, Montalvo D. Prevalencia de Diabetes tipo 2 y obesidad en 2 poblaciones aborígenes de Chile en ambiente urbano. Rev Méd Chile 2004; 132: 1189-1197.
Encuesta Nacional de Salud 2007. Ministerio de Salud, Chile. http://epi.minsal.cl/epi/html/frames/frame3.htm.
Barja S, Arteaga A, Acosta AM, Hodgson I: Resistencia insulínica y otras expresiones del syndrome metabólico en niños obesos chilenos. Rev Med Chile 2003;131:259-68.
Carrasco F, Moreno M, Irribarra I, et al. Evaluación de un programa piloto de intervención en adultos con sobrepeso u obesidad, en riesgo de diabetes: Rev Méd Chile 2008;136:13-21.
Secretaria de Salud. Mortalidad 2001 en México. Salud Pública 2002; 44:571-578.
Prevalencia estimada de diabetes al 2030 por la Federación Internacional de Diabetes (http://www.idf.org http://www.diabetesatlas.org/downloads)
Murgatroyd H, Ellingford A, Cox A, Binnie M, Ellis JD, MacEwen CJ, Leese GP. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004;88:920-4.
Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002;134:204-13.